TXN
59
3
CNP
49
7
MSI
81
9
REGN
42
3
PBI
59
-4
CFG
68
-2
NTAP
64
3
LLY
50
11
IBM
53
2
MS
79
2
TDC
70
15
ALL
50
5
ECL
62
5
MMM
44
2
VTR
50
3
SWKS
39
-6
HRB
59
-7
SBUX
39
7
MCD
60
6
SO
57
7
TXN
59
3
CNP
49
7
MSI
81
9
REGN
42
3
PBI
59
-4
CFG
68
-2
NTAP
64
3
LLY
50
11
IBM
53
2
MS
79
2
TDC
70
15
ALL
50
5
ECL
62
5
MMM
44
2
VTR
50
3
SWKS
39
-6
HRB
59
-7
SBUX
39
7
MCD
60
6
SO
57
7
Financhill
Back

Neurocrine Biosciences Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Buy
60

NBIX
Neurocrine Biosciences

Last Price:
125.65
Seasonality Move:
16.36%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Neurocrine Biosciences Price Quote

$125.65
-0.09 (1.35%)
(Updated: November 9, 2024 at 5:38 AM ET)

Neurocrine Biosciences Key Stats

Buy
60
Neurocrine Biosciences (NBIX) is a Buy
Day range:
$123.76 - $126.28
52-week range:
$103.63 - $157.98
Dividend yield:
0%
P/E ratio:
50.91
P/S ratio:
5.80
P/B ratio:
4.68%
Volume:
560.2K
Avg. volume:
887.2K
1-year change:
8.97%
Market cap:
$12.7B
Revenue:
$1.9B
EPS:
$3.73

How Much Does Neurocrine Biosciences Make?

Is Neurocrine Biosciences Growing As A Company?

Neurocrine Biosciences Stock Price Performance

What Is Neurocrine Biosciences 52-Week High & Low?

Neurocrine Biosciences Price To Free Cash Flow

Is It Risky To Buy Neurocrine Biosciences?

Is Neurocrine Biosciences Cash Flow Positive?

  • What Is NBIX Cash Flow From Operations?
    Cash flow from operations (TTM) is $476.4M
  • What Is Neurocrine Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$161.3M
  • What Is Neurocrine Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$260.3M

Neurocrine Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    NBIX return on invested capital is 15.5%
  • What Is Neurocrine Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is 11.76%
  • What Is NBIX Return On Equity?
    ROE is a measure of profitability and is 16.29%

Neurocrine Biosciences Earnings Date & Stock Price

Neurocrine Biosciences Competitors

Neurocrine Biosciences Dividend Yield

Neurocrine Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 51.22% -0.39%
Revenue: 24.72% 3.21%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 163.10
Upside from Last Price: 29.71%

Major Shareholders

  • How many NBIX shares are owned by institutional investors?
    140.8M NBIX shares are owned by institutional investors
  • How many NBIX shares are owned by insiders?
    2.2M NBIX shares are owned by insiders